使用白纳米载体进行口服梨皮提取物以调节胆固醇吸收
Laura M Teixeira1,2,3, Ana S Viana1,2, Catarina P Reis3,4
1Centro de Química Estrutural, Institute of Molecular Sciences, Faculdade de Ciências, Universidade de Lisboa, 1749-016 Lisboa, Portugal.
Pharmaceutics
|August 28, 2025
概括
将梨皮提取物纳米封装在牛血清白蛋白纳米颗粒中可以提高其稳定性和生物可用性. 这种新型的输送系统通过降低胆固醇吸收来控制高胆固醇血症.
科学领域:
- 生物技术
- 纳米医学
- 营养药物
背景情况:
- 高胆固醇是主要的心血管疾病风险因素,目前的药物造成不良影响.
- 自然产品提供了替代品, 但低生物利用性需要先进的输送系统.
- 梨 (Persea americana) 皮的提取物可以降低胆固醇.
研究的目的:
- 开发和描述包装Persea americana皮的牛血清蛋白纳米颗粒.
- 评估纳米配方的稳定性,安全性和生物可用性.
- 评估纳米配方在降低胆固醇吸收方面的有效性.
主要方法:
- 梨皮提取物被封装在牛血清白蛋白纳米颗粒中.
- 评估了纳米配方的物理化学特性,稳定性和细胞毒性.
- 使用Caco-2细胞模型评估了生物可用性和胆固醇吸收.
主要成果:
- 纳米封装改善了提取物的稳定性和生物可用性,在模拟消化过程中保护它.
- 纳米粒子表现出有利的物理化学特性,并证明了安全性和生物相容性.
- 与自由提取物相比,纳米配方显著降低了Caco-2细胞中的胆固醇透.
结论:
- 梨皮提取物纳米配方提供稳定且可生物利用的口服系统.
- 这种纳米配方为高胆固醇血症治疗提供了有希望的安全策略.
- 建议在治疗代谢障碍方面进一步应用.
相关概念视频
Lipid Absorption
708
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
708
Lipid Digestion
93.8K
Lipids are large molecules that are generally not water-soluble. Since most of the digestive enzymes in the human body are water-based, there are specific steps the body must take to break down lipids and make them available for use.
93.8K
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
4.4K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
4.4K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865
Drug Delivery: Enteral Route
709
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
709
Non-Oral Extravascular Drug Absorption Routes
294
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
294


